Spontaneous mutation rate in retinoblastoma.
Open Access
- 1 June 1990
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 43 (6) , 496-498
- https://doi.org/10.1136/jcp.43.6.496
Abstract
A novel approach was used to estimate the in vivo mutation rate of the retinoblastoma gene. A mathematical formula can be used to calculate the probability of neoplasia induced by one or more mutations in a population of dividing cells. This formula can then be applied to epidemiological data on hereditary and sporadic retinoblastoma. The analysis yields an estimate of the in vivo mutation rate of 8 x 10(-8)/gene/cell division (range 5.5 x 10(-8) to 1.3 x 10(-7]. The estimated non-replication association in vivo mutation rate is 2.4 x 10(-8)/gene/year (range 0 to 6.8 x 10(-8]. The formula is an improvement on previous attempts to produce a model of the process of mutation during cell generation. It can be applied to neoplastic disease in both children and adults.This publication has 20 references indexed in Scilit:
- A mutational theory of leukaemogenesis.Journal of Clinical Pathology, 1989
- Increased somatic cell mutant frequency in atomic bomb survivorsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- What are antioncogenes?The Journal of Pathology, 1988
- Carcinogenesis RevisitedCancer Investigation, 1987
- IS SPONTANEOUS MUTATION THE MAJOR ‘CAUSE’ OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA?British Journal of Haematology, 1986
- Detection of somatic mutations in man: evaluation of the microtitre cloning assay for T-lymphocytesMutagenesis, 1986
- ANTI-ONCOGENESThe Lancet, 1985
- In vivo somatic mutations in human lymphocytes frequently result from major gene alterationsNature, 1985
- ONCOGENESThe Lancet, 1984
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971